改善艾滋病毒暴露前预防 (PrEP) 的采用和启动:从国家PrEP计划的过程评估和建议开发†
Claudia S Estcourt1, Jennifer MacDonald2, John Saunders3
1School of Health & Life Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow G4 0BA, UK; and Sandyford Sexual Health Services, NHS Greater Glasgow & Clyde, 6 Sandyford Place, Glasgow G3 7NB, UK.
Sexual health
|August 21, 2023
概括
实施艾滋病毒暴露前预防 (PrEP) 需要解决资源和培训障碍. 建议侧重于多样化的环境,定制培训和利益相关者的合作,以改善所有人的PrEP吸收和启动.
科学领域:
- 公共卫生 公共卫生
- 实施科学 实施科学
- 预防艾滋病毒 预防艾滋病毒
背景情况:
- 艾滋病毒暴露前预防 (PrEP) 对于消除艾滋病毒传播至关重要.
- 计划实施面临重大挑战,需要进一步研究.
- 本研究评估了国家PrEP计划的最初两年,以确定吸收和启动的障碍和促进者.
研究的目的:
- 探索影响PrEP计划实施的障碍和促进因素.
- 制定基于证据的建议,以优化PrEP的吸收和启动.
- 增强PrEP对所有可能受益的个体的覆盖范围.
主要方法:
- 在苏格兰进行了两阶段的过程评估.
- 第1阶段涉及质量访谈和聚焦小组,与各种利益相关者.
- 第二阶段使用实施科学工具,根据发现产生的建议.
主要成果:
- 多层次的障碍包括快速实施速度和缺乏处方人员熟悉度.
- 促进者涉及知识获取和PrEP启动的规范化.
- 通过专家意见和APEASE标准,开发了41个精确的建议.
结论:
- 该研究为优化PrEP计划提供了一个强大的,基于证据的框架.
- 建议旨在改善在不同环境中PrEP的采用和启动.
- 确保公平获得PrEP对于最大限度地提高公共卫生效益至关重要.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Sexually Transmitted Infections
348
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
348
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K


